Table 2 ∣.
Study | Antibiotic exposure timing |
Date (location) | Study design | Antibiotic data source |
Disease diagnosis |
Key findingsa |
---|---|---|---|---|---|---|
Kronman et al.150 | Childhood | 2012 (UK) | Retrospective cohort | Health records registry | Diagnosis (Read) codes | HR IBD 5.51 (1.66–18.28) — antibiotic exposure before 1 year of age; HR 2.62 (1.61–4.25) — by 5 years of age; HR 1.57 (1.35–1.84) — by 15 years of age Dose dependency |
Hviid et al.151 | Childhood | 2011 (Denmark) | Retrospective cohort | National health registry | Diagnosis (ICD) codes | IBD RR 1.84 (1.08–3.15) Dose dependency |
Nguyen et al.152 | All | 2020 (Sweden) | Case–control | National health registry | Diagnosis (ICD) codes | aOR IBD 1.94 (1.85–2.03) Dose dependency |
Shaw et al.153 | Infants <1 year of age | 2010 (Manitoba, Canada) | Nested case–cohort | Provincial health registry | Diagnosis (ICD) codes | OR IBD 2.9 (1.2–7.0) Dose dependency |
Shaw et al.154 | 2–5 years before diagnosis | 2011 (Manitoba, Canada) | Case–control | Provincial health registry | Diagnosis (ICD) codes | aOR IBD 1.27 (1.20–1.35) Dose dependency |
Card et al.157 | 2–5 years before diagnosis | 2004 (UK) | Case–control | Research database | Diagnosis (Oxmis, Read) codes | aOR IBD (1.05–1.65) No dose dependency |
Virta et al.158 | Childhood | 2012 (Finland) | Case–control | National health registry | Diagnosis (ICD) codes | aOR CD 1.87 (1.37–2.56) aOR UC 1.18 (0.92–1.52) |
Ungaro et al.155 | Variable | 2014 (Europe, Canada, New Zealand) | Meta-analysis | Mostly health registries, some surveys | Varies | Pooled OR IBD 1.57 (1.27–1.94) |
Zou et al.156 | Childhood | 2020 (North America, Eurasia, Oceania) | Meta-analysis | Varies | Varies | Pooled OR IBD 1.5 (1.22–1.85) |
aOR, adjusted odds ratio; CD, Crohn’s disease; IBD, inflammatory bowel disease; ICD, international Classification of Disease; RR, rate ratio; UC, ulcerative colitis.
Value ranges in parentheses are 95% confidence intervals.